Bank of Montreal’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $215M | Sell |
7,667,405
-1,975,174
| -20% | -$52.6M | 0.08% | 199 |
|
|
2025
Q4 | $240M | Buy |
9,642,579
+400,114
| +4% | +$10.1M | 0.08% | 187 |
|
|
2025
Q3 | $235M | Buy |
9,242,465
+636,397
| +7% | +$15.7M | 0.09% | 166 |
|
|
2025
Q2 | $209M | Sell |
8,606,068
-1,186,269
| -12% | -$27.7M | 0.1% | 150 |
|
|
2025
Q1 | $248M | Sell |
9,792,337
-969,442
| -9% | -$25.4M | 0.12% | 139 |
|
|
2024
Q4 | $286M | Sell |
10,761,779
-4,605,455
| -30% | -$125M | 0.13% | 130 |
|
|
2024
Q3 | $447M | Buy |
15,367,234
+287,512
| +2% | +$8.39M | 0.2% | 95 |
|
|
2024
Q2 | $426M | Buy |
15,079,722
+224,272
| +2% | +$6.17M | 0.12% | 100 |
|
|
2024
Q1 | $413M | Buy |
14,855,450
+1,482,055
| +11% | +$41.1M | 0.13% | 104 |
|
|
2023
Q4 | $399M | Sell |
13,373,395
-3,473,979
| -21% | -$105M | 0.12% | 99 |
|
|
2023
Q3 | $623M | Buy |
16,847,374
+2,432,254
| +17% | +$86M | 0.22% | 62 |
|
|
2023
Q2 | $579M | Buy |
14,415,120
+2,487,958
| +21% | +$96.8M | 0.2% | 64 |
|
|
2023
Q1 | $587M | Sell |
11,927,162
-1,523,508
| -11% | -$65.8M | 0.23% | 61 |
|
|
2022
Q4 | $722M | Buy |
13,450,670
+1,417,953
| +12% | +$68M | 0.31% | 44 |
|
|
2022
Q3 | $592K | Sell |
12,032,717
-595,208
| -5% | -$28.9M | 0.26% | 52 |
|
|
2022
Q2 | $655K | Sell |
12,627,925
-1,612,376
| -11% | -$82.2M | 0.3% | 57 |
|
|
2022
Q1 | $757M | Buy |
14,240,301
+858,254
| +6% | +$44.5M | 0.37% | 58 |
|
|
2021
Q4 | $786M | Sell |
13,382,047
-4,283,139
| -24% | -$212M | 0.42% | 47 |
|
|
2021
Q3 | $777M | Buy |
17,665,186
+5,450,866
| +45% | +$241M | 0.35% | 56 |
|
|
2021
Q2 | $483M | Buy |
12,214,320
+1,579,179
| +15% | +$61.4M | 0.24% | 84 |
|
|
2021
Q1 | $382M | Sell |
10,635,141
-42,503
| -0.4% | -$1.51M | 0.25% | 80 |
|
|
2020
Q4 | $403M | Buy |
10,677,644
+763,978
| +8% | +$28M | 0.27% | 83 |
|
|
2020
Q3 | $340M | Sell |
9,913,666
-914,410
| -8% | -$32.1M | 0.28% | 77 |
|
|
2020
Q2 | $344M | Sell |
10,828,076
-546,530
| -5% | -$18.6M | 0.31% | 68 |
|
|
2020
Q1 | $355M | Sell |
11,374,606
-4,629,695
| -29% | -$158M | 0.41% | 55 |
|
|
2019
Q4 | $595M | Sell |
16,004,301
-641,928
| -4% | -$22.9M | 0.45% | 43 |
|
|
2019
Q3 | $567M | Sell |
16,646,229
-1,510,065
| -8% | -$54.9M | 0.49% | 42 |
|
|
2019
Q2 | $746M | Sell |
18,156,294
-52,788
| -0.3% | -$2.1M | 0.63% | 31 |
|
|
2019
Q1 | $734M | Sell |
18,209,082
-2,083,724
| -10% | -$83.4M | 0.63% | 29 |
|
|
2018
Q4 | $840M | Sell |
20,292,806
-2,922,826
| -13% | -$121M | 0.79% | 22 |
|
|
2018
Q3 | $971M | Buy |
23,215,632
+311,567
| +1% | +$12M | 0.76% | 22 |
|
|
2018
Q2 | $788M | Sell |
22,904,065
-535,502
| -2% | -$18.3M | 0.65% | 30 |
|
|
2018
Q1 | $789M | Buy |
23,439,567
+4,895,690
| +26% | +$168M | 0.7% | 27 |
|
|
2017
Q4 | $637M | Buy |
18,543,877
+383,261
| +2% | +$13.1M | 0.55% | 34 |
|
|
2017
Q3 | $615M | Sell |
18,160,616
-1,374,388
| -7% | -$44.2M | 0.56% | 30 |
|
|
2017
Q2 | $623M | Buy |
19,535,004
+233,811
| +1% | +$7.37M | 0.6% | 28 |
|
|
2017
Q1 | $626M | Buy |
19,301,193
+1,130,180
| +6% | +$35.6M | 0.59% | 29 |
|
|
2016
Q4 | $554M | Sell |
18,171,013
-1,932,291
| -10% | -$59M | 0.58% | 28 |
|
|
2016
Q3 | $646M | Sell |
20,103,304
-1,324,024
| -6% | -$44.3M | 0.71% | 25 |
|
|
2016
Q2 | $716M | Buy |
21,427,328
+2,714,696
| +15% | +$86.6M | 0.82% | 23 |
|
|
2016
Q1 | $526M | Sell |
18,712,632
-599,114
| -3% | -$17.1M | 0.56% | 30 |
|
|
2015
Q4 | $591M | Sell |
19,311,746
-1,065,418
| -5% | -$33.5M | 0.71% | 21 |
|
|
2015
Q3 | $607M | Buy |
20,377,164
+6,832,832
| +50% | +$219M | 0.84% | 20 |
|
|
2015
Q2 | $431M | Sell |
13,544,332
-35,945
| -0.3% | -$1.17M | 0.5% | 32 |
|
|
2015
Q1 | $448M | Sell |
13,580,277
-6,789,299
| -33% | -$216M | 0.52% | 31 |
|
|
2014
Q4 | $602M | Buy |
20,369,576
+4,165,053
| +26% | +$119M | 0.68% | 24 |
|
|
2014
Q3 | $455M | Sell |
16,204,523
-465,477
| -3% | -$13.1M | 0.51% | 33 |
|
|
2014
Q2 | $469M | Buy |
16,670,000
+755,322
| +5% | +$21.5M | 0.52% | 34 |
|
|
2014
Q1 | $485M | Sell |
15,914,678
-1,078,248
| -6% | -$32.1M | 0.63% | 28 |
|
|
2013
Q4 | $494M | Buy |
16,992,926
+2,826,632
| +20% | +$82.3M | 0.68% | 28 |
|
|
2013
Q3 | $386M | Buy |
14,166,294
+860,557
| +6% | +$23.4M | 0.6% | 32 |
|
|
2013
Q2 | $354M | Buy |
+13,305,737
| New | +$368M | 0.63% | 31 |
|
Other funds holding PFE
VCM
VPM
Bank of Montreal's PFE Position: Q1 2026 in Review
Bank of Montreal reduced its Pfizer (PFE) stake by 20% in Q1 2026, selling an estimated $52.6M and leaving 7,667,405 shares worth $215M. The position accounts for 0.08% of the portfolio, ranked #199.
Bank of Montreal first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $971M in Q3 2018. 2,938 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Bank of Montreal held 7,667,405 shares of Pfizer worth $215M as of Q1 2026.
- Bank of Montreal sold 1,975,174 Pfizer shares in Q1 2026, an estimated $52.6M.
- Pfizer made up 0.08% of Bank of Montreal's portfolio in Q1 2026, its #199 holding.
- Bank of Montreal first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
- Bank of Montreal's Pfizer position peaked at $971M in Q3 2018.
- 2,938 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Bank of Montreal's 13F filing for Q1 2026, filed 13 May 2026.